SS
ABEO icon

SBI Securities’s Abeona Therapeutics ABEO Stock Holding History

SBI Securities’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408 Sell
66
-8
-11% -$44 ﹤0.01% 3108
2026
Q1 		$332 Sell
74
-4
-5% -$20 ﹤0.01% 3034
2025
Q4 		$411 Sell
78
-117
-60% -$589 ﹤0.01% 2945
2025
Q3 		$1.03K Buy
195
+33
+20% +$209 ﹤0.01% 2683
2025
Q2 		$920 Sell
162
-396
-71% -$2.25K ﹤0.01% 2716
2025
Q1 		$2.66K Buy
558
+341
+157% +$1.85K ﹤0.01% 2175
2024
Q4 		$1.21K Buy
+217
New +$1.33K ﹤0.01% 2524

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SBI Securities's ABEO Position: Q2 2026 in Review

SBI Securities reduced its Abeona Therapeutics (ABEO) stake by 11% in Q2 2026, selling an estimated $44 and leaving 66 shares worth $408. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

SBI Securities first reported a position in ABEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.66K in Q1 2025. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • SBI Securities held 66 shares of Abeona Therapeutics worth $408 as of Q2 2026.
  • SBI Securities sold 8 Abeona Therapeutics shares in Q2 2026, an estimated $44.
  • Abeona Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3108 holding.
  • SBI Securities first reported a position in Abeona Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Abeona Therapeutics position peaked at $2.66K in Q1 2025.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.